Effect of Cell Culture Medium on the Proliferation and Stemness of CD24-/CD44+ Human Breast Cancer Stem Cells
Abstract
BACKGROUND: Cancer stem cells (CSCs) is defined as tumor initiating cells within tumor that maintain stemness properties and tumorigenicity. Extracellular pH of CSCs in in vitro condition is important for supporting cell proliferation which may also regulate the expression of stemness markers such as OCT4. This work aimed to examine the effect of cell culture media on the proliferation and stemness of human breast cancer stem cells (BCSCs).
METHODS: Human CD24-/CD44+ BCSCs were grown in Dulbecco's Modified Eagle Medium/F-12 (DMEM/F-12) with 15mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), without HEPES and adjusted to pH 7.4, or without HEPES but pH was not adjusted. BCSCs were grown under standard conditions for various days. Viable cell number was measured using trypan blue exclusion, whereas proliferation rate using MTS assay. OCT4 mRNA and protein were analyzed using quantitative real time PCR (qRT-PCR) and Western Blot assay, respectively. In vitro tumorigenic activity was determined using mammosphere formation unit (MFU) assay.
RESULTS: Our results showed a higher viable cell number and proliferation of BCSCs in DMEM/F-12 HEPES (-) compared to HEPES (+) medium until 4 day incubation. OCT4 mRNA and protein level, as well as MFU of BCSCs were significantly higher in HEPES (-) compared to HEPES (+) medium on day 2.
CONCLUSION: DMEM/F-12 medium without HEPES facilitates CD24-/CD44+ BCSCs to have higher proliferation and stemness on day 2 incubation compared to those with HEPES.
KEYWORDS: breast cancer, cancer stem cell, OCT4, stemness, proliferation
Full Text:
PDFReferences
Sarkar S, Horn G, Moulton K, Oza A, Byler S, Kokolus S, et al. Cancer development, progression, and therapy: An epigenetic overview. Int J Mol Sci. 2013; 14: 21087–113, CrossRef.
Liu Y, Nenutil R, Appleyard M V., Murray K, Boylan M, Thompson AM, et al. Lack of correlation of stem cell markers in breast cancer stem cells. Br J Cancer. 2014; 110: 2063–71, CrossRef.
He J, Xiong L, Li Q, Lin L, Miao X, Yan S, et al. 3D modeling of cancer stem cell niche. Oncotarget. 2018; 9: 1326–45, CrossRef.
Ayob AZ, Ramasamy TS. Cancer stem cells as key drivers of tumour progression. J Biomed Sci. 2018; 25: 1–18, CrossRef.
Wanandi SI, Yustisia I, Neolaka GMG, Jusman SWA. Impact of extracellular alkalinization on the survival of human CD24-/CD44+ breast cancer stem cells associated with cellular metabolic shifts. Brazilian J Med Biol Res. 2017; 50: 1–11. e6538, CrossRef.
Hepburn AC, Steele RE, Veeratterapillay R, Wilson L, Kounatidou EE, Barnard A, et al. The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance. Oncogene. 2019; 38: 4412–24, CrossRef.
Kim RJ, Nam JS. OCT4 expression enhances features of cancer stem cells in a mouse model of breast cancer. Lab Anim Res. 2011; 27: 147-52, CrossRef.
Wang Y, Herlyn M. The emerging roles of Oct4 in tumor-initiating cells. Am J Physiol Cell Physiol. 2015; 309: C709–18. Wang Y, Herlyn M. The emerging roles of Oct4 in tumor-initiating cells. Am J Physiol Cell Physiol. 2015; 309: C709–18, CrossRef.
Lombardo Y, de Giorgio A, Coombes CR, Stebbing J, Castellano L. Mammosphere formation assay from human breast cancer tissues and cell lines. J Vis Exp. 2015; 97: 52671, CrossRef.
De Angelis ML, Francescangeli F, Zeuner A. Breast cancer stem cells as drivers of tumor chemoresistance, dormancy and relapse: New challenges and therapeutic opportunities. Cancers (Basel). 2019; 11: 1569, CrossRef.
Hao G, Xu ZP, Li L. Manipulating extracellular tumour pH: An effective target for cancer therapy. RSC Adv. 2018; 8: 22182–92, CrossRef.
Michl J, Park KC, Swietach P. Evidence-based guidelines for controlling pH in mammalian live-cell culture systems. Commun Biol. 2019; 2: 144, CrossRef.
Ferguson WJ, Braunschweiger KI, Braunschweiger WR, Smith JR, McCormick JJ, Wasmann CC, et al. Hydrogen ion buffers for biological research. Anal Biochem. 1980; 104: 300–10, CrossRef.
Wanandi SI, Limanto A, Yunita E, Syahrani RA, Louisa M, Wibowo AE, et al. In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells. PLoS One. 2020; 15: e0240020, CrossRef.
Fang DD, Kim YJ, Lee CN, Aggarwal S, McKinnon K, Mesmer D, et al. Expansion of CD133+ colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. Br J Cancer. 2010; 102: 1265–75, CrossRef.
Hosea R, Hardiany NS, Ohneda O, Wanandi SI. Glucosamine decreases the stemness of human ALDH+ breast cancer stem cells by inactivating STAT3. Oncol Lett. 2018; 16: 4737–44, CrossRef.
Chan GKY, Kleinheinz TL, Peterson D, Moffat JG. A simple high-content cell cycle assay reveals frequent discrepancies between cell number and ATP and MTS proliferation assays. PLoS One. 2013; 8: e63583, CrossRef.
Wanandi SI, Syahrani RA, Arumsari S, Wideani G, Hardiany NS. Profiling of gene expression associated with stemness and aggressiveness of ALDH1A1-expressing human breast cancer cells. Malaysian J Med Sci. 2019; 26: 38–52, CrossRef.
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 2001; 25: 402–8, CrossRef.
Price PJ. Best practices for media selection for mammalian cells. Vitr Cell Dev Biol - Anim. 2017; 53: 673–81, CrossRef.
Heiden MGV, Cantley LC, Thompson CB. Understanding the warburg effect: The metabolic requirements of cell proliferation. Science. 2009; 324: 1029–33, CrossRef.
Bowman CM, Berger EM, Butler EN, Toth KM, Repine JE. HEPES may stimulate cultured endothelial cells to make growth-retarding oxygen metabolites. Vitr Cell Dev Biol. 1985; 21: 140–2, CrossRef.
Depping R, Seeger K. 1 H-NMR spectroscopy shows cellular uptake of HEPES buffer by human cell lines—an effect to be considered in cell culture experiments. Anal Bioanal Chem. 2019; 411: 797–802, CrossRef.
Luo S, Pal D, Shah SJ, Kwatra D, Paturi KD, Mitra AK. Effect of HEPES buffer on the uptake and transport of P- glycoprotein substrates and large neutral amino acids. Bone. 2014; 23: 1–7, CrossRef.
Lepe-Zuniga JL, Zigler JS, Gery I. Toxicity of light-exposed Hepes media. J Immunol Methods. 1987; 103: 145, CrossRef.
Alowaidi F, Hashimi SM, Alqurashi N, Alhulais R, Ivanovski S, Bellette B, et al. Assessing stemness and proliferation properties of the newly established colon cancer ‘stem’ cell line, CSC480 and novel approaches to identify dormant cancer cells. Oncol Rep. 2018; 39: 2881–91, CrossRef.
Kleffel S, Schatton T. Tumor dormancy and cancer stem cells: two sides of the same coin? Adv Exp Med Biol. 2013; 734: 145-79, CrossRef.
Shaw FL, Harrison H, Spence K, Ablett MP, Simões BM, Farnie G, et al. A detailed mammosphere assay protocol for the quantification of breast stem cell activity. J Mammary Gland Biol Neoplasia. 2012; 17: 111–7, CrossRef.
DOI: https://doi.org/10.18585/inabj.v13i4.1674
Copyright (c) 2021 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
